Important Notice: Our Bank Account Remain Unchanged
MEDICA 2026
WHX Dubai

WHAT'S NEW

Aristo Ur
One instrument for detection, automatic reporting of ACR and the ratio of multiple urinary proteins to creatinine.
GSH-120
120 tests/hour high-capacity HPLC HbA1c analyzer
GSH-50 HPLC HbA1c
The Answer to Affordable HPLC HbA1c.
Offers specialized Normal, Variant, and Thalassemia modes to deliver accurate, tailored diagnostics

Take A Look At Our Core Products

    First-class quality
    This area can be customized to add text, the length of the text is customized, does not affect the operation of the entire site.This area can be customized to add text, the length of the text is customized, does not affect the operation of the entire site.

    Focusing on In Vitro Diagnostics R&D and Manufacturing Since 1999

    Goldsite Diagnostics Inc., founded in 1999, is a leading Chinese diagnostics manufacturer specializing in in-vitro diagnostics devices and reagents. For over 27 years, we have been keeping developing and producing high quality products, from China’s first Specific Protein Analyzer to the most innovative nephelometer, GPP-100, from our renowned nephelometry kits (e.g. China’s First-class quality CRP, NGSP certified HbA1c, etc.) to all those never-compromised CLIA, biochemistry and HPLC reagents. With all products CE marked, our market presence currently spreads from across China to more than 100 countries, Goldsite is expanding its footprint to become a global brand.
    27
    years

    Established

    500
    +
    Staff
    30000
    ㎡
    Factory Square
    100
    +
    Overseas Market

    International Advanced Reagent R&D And Production Center

    Goldsite Diagnostics Inc. brings together professionals with cutting-edge technology from home and abroad (more than 60% hold master's degree or above), introduces advanced testing technology from home and abroad, efficiently integrates global resources, has established several instrument R&D core project departments and reagent project R&D platforms, launched several instruments and reagent products, and has several forward-looking projects in the R&D stage. The company takes R&D innovation as the fundamental, and vigorously increases R&D investment to ensure the smooth implementation of scientific and technological projects.

    Certificate

    ​​​​​​​

    Applications Insights​​​​​​​

    /
    Inflammation | Pneumonia
    CRP
    /
    COVID-19
    SARS-CoV-2
    /
    Diabetes
    HbA1c
    /
    Thrombosis
    D-Dimer
    /
    Rheumatoid Arthritis
    Anti-CCP
    /
    Pregnancy
    /
    Thyroid

    News

    Goldsite Diagnostics Wraps Up a Successful MEDICA 2026 with New Launches and Integrated Diabetes-CKD Solutions

    COMPANY NEWS · MEDICA 2026 MEDICA 2026 Closes New launches and integrated Diabetes-CKD solutions   Düsseldorf, Germany · 19 November 2026 · Hall 1 · Stand B56 Today marks the successful conclusion of MEDICA 2026 (16–19 November 2026, Messe Düsseldorf). Marking 27+ years

    Goldsite Diagnostics at MEDICA 2026 | World Premiere of GSH-120

    Goldsite Diagnostics at MEDICA 2026 | World Premiere of GSH-120   COMPANY NEWS GSH-120 Debuts at MEDICA 2026 High-Throughput Ion-Exchange HPLCHbA1c Analyzer   Hall 1 · Stand B56  |  16–19 November 2026  |  Messe Düsseldorf, Germany

    Customer Distribution

    Contact Us For The Latest Quotation

    Get in touch

    Copyright © 1999- 2026 Goldsite Diagnostics Inc., All rights reserved.   Sitemap